Abstract

Borderline personality disorder (BPD) is characterized by instability of affect, emotion dysregulation, and interpersonal dysfunction. Especially shame and guilt, so-called self-conscious emotions, are of central clinical relevance to BPD. However, only few experimental studies have focused on shame or guilt in BPD and none investigated their neurobiological underpinnings. In the present functional magnetic resonance imaging study, we took a scenario-based approach to experimentally induce feelings of shame, guilt, and disgust with neutral scenarios as control condition. We included 19 women with BPD (age 26.4 ± 5.8 years; DSM-IV diagnosed; medicated) and 22 healthy female control subjects (age 26.4 ± 4.6 years; matched for age and verbal IQ). Compared to controls, women with BPD reported more intense feelings when being confronted with affective scenarios, especially higher levels of shame, guilt, and fear. We found increased amygdala reactivity in BPD compared to controls for shame and guilt, but not for disgust scenarios (p = 0.05 FWE corrected at the cluster level; p < 0.0001 cluster defining threshold). Exploratory analyses showed that this was caused by a diminished habituation in women with BPD relative to control participants. This effect was specific to guilt and shame scenarios as both groups showed amygdala habituation to disgust scenarios. Our work suggests that heightened shame and guilt experience in BPD is not related to increased amygdala activity per se, but rather to decreased habituation to self-conscious emotions. This provides an explanation for the inconsistencies in previous imaging work on amygdala involvement in BPD as well as the typically slow progress in the psychotherapy of dysfunctional self-conscious emotions in this patient group.

Details

Title
Neural basis of shame and guilt experience in women with borderline personality disorder
Author
Göttlich, Martin 1 ; Westermair, Anna Lisa 2 ; Beyer Frederike 3 ; Bußmann, Marie Luise 2 ; Schweiger, Ulrich 2 ; Krämer, Ulrike M 4   VIAFID ORCID Logo 

 University of Lübeck, Department of Neurology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672) 
 University of Lübeck, Department of Psychiatry and Psychotherapy, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672) 
 Queen Mary University of London, School of Biological and Chemical Sciences, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133) 
 University of Lübeck, Department of Neurology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672); University of Lübeck, Institute for Psychology II, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672) 
Pages
979-992
Publication year
2020
Publication date
Dec 2020
Publisher
Springer Nature B.V.
ISSN
09401334
e-ISSN
14338491
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471651375
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.